about
mission / vision
our team
board members

executive leadership

scientists
careers
postdoctoral programs

internship programs

current job opportunities
|  |
Mission / Vision
our mission

IDRI's mission is to develop novel, advanced products for the diagnosis, prevention and treatment of neglected diseases of poverty. IDRI brings diverse talents and resources together and applies them to solve intractable global health problems. Our emphasis on the final goal line — products on the market — sets us apart from other not for profit research groups. We strive to apply the world's best science to the world's worst diseases, and to do so through collaborations and teamwork.
Message from our Founder

As an undergraduate, I had an advisor who worked on infectious diseases in Central America. Through my work with him I became aware of the tremendous global health challenges posed by infectious diseases, and the equally substantial opportunities to make a difference in millions of lives by developing solutions to these challenges. I haven't looked back since.
I established IDRI in 1993 in order to apply advances in immunology to the development of novel diagnostics, vaccines, and therapeutic products that could transform the lives of the millions of people at risk for infectious diseases throughout the developing world. As a scientist with experience in both the academic and biotechnology arenas, I wanted to build an institution that combined the high quality science of a research organization with the product development and production capabilities of a biotechnology company.
Since our inception we have attracted a dedicated team of scientists who have keen minds, compassionate hearts, and entrepreneurial spirits. Together, we have created a unique institution that has the flexibility to collaborate with a diverse group of partners, including leading life science companies, research centers, universities, government organizations, and NGOs. This collaborative approach brings disparate resources together to solve difficult global health challenges.
Today, we are focused on eradicating tuberculosis, leishmaniasis, leprosy, malaria, and Chagas Disease. As the global health arena evolves, our commitment to improving human health and our pragmatic focus on products should enable us to continue translating science into global health solutions.
IDRI was founded to develop products that save lives, and I'm proud of what we have already done to achieve that goal. The diagnostics, vaccines, and therapeutic approaches that we have enabled have made a difference in millions of lives. We remain committed to helping millions more.
Sincerely,
Steven G. Reed
Founder, President, & Chief Scientific Officer
Infectious Disease Research Institute
|